CVE-2024-43795 OpenC3 COSMOS vulnerable to cross-site scripting in Login functionality (`GHSL-2024-128`)
Attackers can execute arbitrary scripts in users' browsers via the login page, potentially leading to session hijacking or data theft.
- Exploited in the wild
- Not known
- Login needed
- Not needed
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- Available
What is CVE-2024-43795?
CVE-2024-43795 is a medium-severity cross-site scripting vulnerability in OpenC3 cosmos, published on 2 Oct 2024. An attacker can exploit it over the internet without logging in, and only if a user opens a file or follows a link.
Official description
OpenC3 COSMOS provides the functionality needed to send commands to and receive data from one or more embedded systems. The login functionality contains a reflected cross-site scripting (XSS) vulnerability. This vulnerability is fixed in 5.19.0. Note: This CVE only affects Open Source Edition, and not OpenC3 COSMOS Enterprise Edition.
Weakness: CWE-79
Which versions are affected by CVE-2024-43795?
7 open source packages ship an affected version, including openc3 and @openc3/tool-common. It affects 1 product.
| Package | Affected | Fixed in |
|---|---|---|
openc3 PyPI | All versions | 5.19.0 |
openc3 PyPI | All versions | 5.19.0 |
openc3 PyPI | All versions | 5.19.0 |
openc3 RubyGems | All versions | 5.19.0 |
openc3 RubyGems | All versions | 5.19.0 |
@openc3/tool-common npm | All versions | 5.19.0 |
1 more packages
@openc3/tool-common npm | All versions | 5.19.0 |
Products include Openc3 Cosmos.
How do I fix CVE-2024-43795?
Upgrade openc3 to 5.19.0 or later.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2024-43795 being exploited?
There is no known exploitation of CVE-2024-43795 in the wild and no public exploit code.
Other vulnerabilities in OpenC3 cosmos
Sources
Also known as GHSA-vfj8-5pj7-2f9g, PYSEC-2024-100.